VALERIAN

OTHER NAME(S):

All-Heal, Amantilla, Baldrian, Baldrianwurzel, Belgium Valerian, Common Valerian, Fragrant Valerian, Garden Heliotrope, Garden Valerian, Grande Valériane, Guérit Tout, Herbe à la Femme Meurtrie, Herbe aux Chats, Herbe aux Coupures, Herbe de Notre-Dame, Herbe de Saint-Georges, Herbe du Loup, Indian Valerian, Mexican Valerian, Pacific Valerian, Rhizome de Valériane, Tagar, Tagar-Ganthoda, Tagara, Valeriana, Valeriana angustifolia, Valeriana edulis, Valeriana fauriei, Valeriana jatamansii, Valeriana officinalis, Valeriana Pseudofficinalis, Valeriana Rhizome, Valeriana sitchensis, Valeriana wallichii, Valerianae Radix, Valeriane, Valériane, Valériane à Petites Feuilles, Valériane Africaine, Valériane Celtique, Valériane Commune, Valériane de Belgique, Valériane des Collines, Valériane Dioïque, Valériane du Jardin, Valériane Indienne, Valériane Mexicaine, Valériane Officinale, Valériane Sauvage.<br/><br/>

Overview

Overview Information

Valerian is an herb. It is native to Europe and parts of Asia but also grows in North America. Medicine is made from the root.

Valerian is most commonly used for sleep disorders, especially the inability to sleep (insomnia). Valerian is also used orally for anxiety and psychological stress, but there is limited scientific research to support these uses.

In manufacturing, the extracts and oil made from valerian are used as flavoring in foods and beverages.

How does it work?

Valerian seems to act like a sedative on the brain and nervous system.

Uses

Uses & Effectiveness?

Possibly Effective for

  • Inability to sleep (insomnia). Although some conflicting research exists, most studies show that taking valerian can reduce the amount of time it takes to fall asleep by about 15 to 20 minutes. Valerian also seems to improve sleep quality. Doses of 400-900 mg of valerian extract taken up to 2 hours before bed seem to work best. Continuous use for several days, even up to four weeks, may be needed before an effect is noticeable. Some studies show that valerian can help improve sleep when combined with other herbs, including hops and lemon balm. Taking valerian might also improve the sleep quality of people who are withdrawing from the use of sleeping pills. However, some research suggests that valerian does not relieve insomnia as fast as "sleeping pills."
  • Menopausal symptoms. Research shows that taking 225 mg of valerian root three times daily for 8 weeks can reduce the severity and frequency of hot flashes in postmenopausal women.

Insufficient Evidence for

  • Anxiety. There is contradictory evidence about the effectiveness of valerian for anxiety. Some early research shows that taking valerian may reduce anxiety. However, other studies have shown no effect. The conflicting results may be due to differences in doses used or the type/severity of anxiety being treated.
  • Depression. Early research suggests that taking valerian plus St. John's wort improves symptoms of depression. Taking higher doses of valerian (1000 mg) with St. John's wort improves depression symptoms faster than low doses (500 mg).
  • Menstrual disorders (dysmenorrhea). Early research suggests that taking 255 mg of valerian three times daily for two menstrual cycles reduces pain and the need for other pain relievers during menstruation.
  • Restlessness. Early research suggests that taking one or two tablets of a specific combination product, providing 160 mg of valerian root extract and 80 mg of lemon balm leaf extract once or twice daily might reduce symptoms of serious restlessness (dyssomnia) in children under the age of 12.
  • Stress. Early research suggests that taking 600 mg of valerian for 7 days before a mental stress test reduces blood pressure, heart rate, and feelings of pressure when under stress. Other research found that taking 100 mg of valerian before speaking in front of an audience reduces feelings of anxiety. Another study found that taking a single doses of a combination product containing 360 mg of valerian and 240 mg of lemon balm night lower anxiety caused by stress. However, the combination seems to increase anxiety when taken in larger doses of 1080 mg of valerian and 720 mg of lemon balm.
  • Attention-deficit hyperactivity disorder (ADHD).
  • Chronic fatigue syndrome (CFS).
  • Convulsions.
  • Epilepsy.
  • Headache.
  • Menopausal symptoms including hot flashes and anxiety.
  • Mild tremors.
  • Muscle and joint pain.
  • Stomach upset.
  • Other conditions.
More evidence is needed to rate the effectiveness of valerian for these uses.

Side Effects

Side Effects & Safety

Valerian is LIKELY SAFE for most people when used in medicinal amounts short-term. Clinical research has reported safe use of valerian for medicinal purposes in over 12,000 people in studies lasting up to 28 days. The safety of long-term use is unknown. Some information suggests that valerian is POSSIBLY SAFE when taken by children for 4-8 weeks.

Valerian can cause some side effects such as headache, stomach upset, mental dullness, excitability, uneasiness, heart disturbances, and even insomnia in some people. A few people feel sluggish in the morning after taking valerian, especially at higher doses. Some people experience dry mouth or vivid dreams. It's best not to drive or operate dangerous machinery after taking valerian. The long-term safety of valerian is unknown. It might cause withdrawal symptoms when discontinued after long-term use. To avoid possible side effects when discontinuing valerian after long-term use, it's best to reduce the dose slowly over a week or two before stopping completely.

Special Precautions & Warnings:

Pregnancy or breast-feeding: There isn't enough information about the safety of valerian during pregnancy or breast-feeding. Stay on the safe side and avoid use.

Surgery: Valerian slows down the central nervous system. Anesthesia and other medications used during surgery also affect the central nervous system. The combined effects might be harmful. Stop taking valerian at least two weeks before a scheduled surgery.

Interactions

Interactions?

Major Interaction

Do not take this combination

!
  • Alcohol interacts with VALERIAN

    Alcohol can cause sleepiness and drowsiness. Valerian might also cause sleepiness and drowsiness. Taking large amounts of valerian along with alcohol might cause too much sleepiness.

  • Alprazolam (Xanax) interacts with VALERIAN

    Valerian can decrease how quickly the liver breaks down alprazolam. Taking valerian with alprazolam might increase the effects and side effects of alprazolam such as drowsiness.

  • Sedative medications (Benzodiazepines) interacts with VALERIAN

    Valerian might cause sleepiness and drowsiness. Drugs that cause sleepiness and drowsiness are called sedatives. Taking valerian along with sedative medications might cause too much sleepiness.<br /> Some of these sedative medications include alprazolam (Xanax), clonazepam (Klonopin), diazepam (Valium), lorazepam (Ativan), midazolam (Versed), temazepam (Restoril), triazolam (Halcion), and others.

  • Sedative medications (CNS depressants) interacts with VALERIAN

    Valerian might cause sleepiness and drowsiness. Medications that cause sleepiness are called sedatives. Taking valerian along with sedative medications might cause too much sleepiness. Taking valerian along with sedative medications used in surgery might cause prolonged sedation.<br /> Some sedative medications include pentobarbital (Nembutal), phenobarbital (Luminal), secobarbital (Seconal), thiopental (Pentothal), fentanyl (Duragesic, Sublimaze), morphine, propofol (Diprivan), and others.

Moderate Interaction

Be cautious with this combination

!
  • Medications changed by the liver (Cytochrome P450 3A4 (CYP3A4) substrates) interacts with VALERIAN

    Some medications are changed and broken down by the liver.<br /> Valerian might decrease how quickly the liver breaks down some medications. Taking valerian along with some medications that are broken down by the liver can increase the effects and side effects of some medications. Before taking valerian, talk to your healthcare provider if you are taking any medications that are changed by the liver.<br /> Some medications changed by the liver include lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), and many others.

Dosing

Dosing

The following doses have been studied in scientific research:

ADULTS

BY MOUTH:

  • For inability to sleep (insomnia):
    • 400-900 mg valerian extract before bedtime for as long as 6 weeks, or
    • 120 mg of valerian extract, with 80 mg of lemon balm extract before bedtime for up to 30 days, or
    • 374-500 mg of valerian extract plus 83.8-120 mg of hops extract before bedtime for 2-4 weeks, or
    • 300 mg of valerian extract, 80 mg of passionflower extract, and 30 mg of hops extract before bedtime for up to two weeks.
    • Take valerian 30 minutes to 2 hours before bedtime.
  • For menopausal symptoms: : 225 mg of ground valerian root has been taken three times daily for 8 weeks.

View References

REFERENCES:

  • Al Majed, A. A., Al Yahya, A. A., Al Bekairi, A. M., Al Shabanah, O. A., and Qureshi, S. Studies on the cytological and biochemical effects of valerian in somatic and germ cells of Swiss albino mice. Food Chem Toxicol 2006;44(11):1830-1837. View abstract.
  • Alkharfy, K. M. and Frye, R. F. Effect of valerian, valerian/hops extracts, and valerenic acid on glucuronidation in vitro. Xenobiotica 2007;37(2):113-123. View abstract.
  • Boeters VU. [On treatment of control disorders of the autonomic nervous system with valepotriaten (Valmane)]. MMW 1969;37:1873-1876.
  • Bounthanh, C., Bergmann, C., Beck, J. P., Haag-Berrurier, M., and Anton, R. Valepotriates, a new class of cytotoxic and antitumor agents. Planta Med. 1981;41(1):21-28. View abstract.
  • Bounthanh, C., Richert, L., Beck, J. P., Haag-Berrurier, M., and Anton, R. The action of valepotriates on the synthesis of DNA and proteins of cultured hepatoma cells. Planta Med. 1983;49(3):138-142. View abstract.
  • Brattstrom, A. Scientific evidence for a fixed extract combination (Ze 91019) from valerian and hops traditionally used as a sleep-inducing aid. Wien.Med Wochenschr. 2007;157(13-14):367-370. View abstract.
  • Cerny AS and Schmid K. Tolerability and efficacy of valerian/lemon balm in healthy volunteers; a double blind placebo controlled, multicentre study. Fitoterapia 1999;70(3):221-228.
  • Chen, J. H., Chao, Y. H., Lu, S. F., Shiung, T. F., and Chao, Y. F. The effectiveness of valerian acupressure on the sleep of ICU patients: a randomized clinical trial. Int J Nurs.Stud. 2012;49(8):913-920. View abstract.
  • Delsignore R, Orlando S, Costi D, Baroni MC, and Butturini. Placebo controlled clinical trial with valerian. Settimana Medica 1980;68(9):437-447.
  • Dimpfel, W., Brattstrom, A., and Koetter, U. Central action of a fixed Valerian-hops extract combination (Ze 91019) in freely moving rats. Eur J Med Res 11-30-2006;11(11):496-500. View abstract.
  • Dimpfel, W., Koch, K., and Weiss, G. Early effect of NEURAPAS(R) balance on current source density (CSD) of human EEG. BMC.Psychiatry 2011;11:123. View abstract.
  • Dominguez, R. A., Bravo-Valverde, R. L., Kaplowitz, B. R., and Cott, J. M. Valerian as a hypnotic for Hispanic patients. Cultur.Divers.Ethni.Minor.Psychol. 2000;6(1):84-92. View abstract.
  • Dressing H, Kohler S, and Muller WE. Improvement in sleep quality with a high dose valerian-melissa preparation. Psychopharmakotherapie 1996;3:123-130.
  • Dressing H. Valerian combination therapy vs. benzodiazepine: same efficacy in the treatment of sleeping disorders? Therapiewoche 1992;42(12):726-736.
  • Friede, M., Liske, E., Woelk, H., and Wustenberg, P. Pflanzliche Wirkstoffe gegen Schlafstorungen. Tw Neurologie Psychiatrie 1997;11(10):697-700.
  • Fussel, A., Wolf, A., and Brattstrom, A. Effect of a fixed valerian-Hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res 9-18-2000;5(9):385-390. View abstract.
  • Gerhard, U., Hobi, V., Kocher, R., and Konig, C. [Acute sedatiing effect of a herbal tranquilizer compared to that of bromazepam]. Schweiz.Rundsch.Med.Prax. 12-27-1991;80(52):1481-1486. View abstract.
  • Gerhard, U., Linnenbrink, N., Georghiadou, C., and Hobi, V. Vigilanzmindernde Effekte zweier pflazlicher Schlafmittel (Effects of two plant-based sleep remedies on vigilance). Schweiz.Rundsch.Med.Prax. 4-9-1996;85(15):473-481. View abstract.
  • Gessner B, Klasser M, and Völp A. [Long term effect of a valerian extract (harmonicum much) in persons with sleep disorders]. Therapiewoche 1983;33:5547-5558.
  • Gessner, B. and Klasser, M. [Studies on the effect of Harmonicum Much on sleep using polygraphic EEG recordings]. EEG.EMG.Z.Elektroenzephalogr.Elektromyogr.Verwandte.Geb. 1984;15(1):45-51. View abstract.
  • Giedke, H. and Breyer-Pfaff, U. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 2000;33(6):239. View abstract.
  • Han, Z. Z., Yan, Z. H., Liu, Q. X., Hu, X. Q., Ye, J., Li, H. L., and Zhang, W. D. Acylated iridoids from the roots of Valeriana officinalis var. latifolia. Planta Med 2012;78(15):1645-1650. View abstract.
  • Hendriks, H., Bos, R., Allersma, D. P., Malingre, T. M., and Koster, A. S. Pharmacological screening of valerenal and some other components of essential oil of Valeriana officinalis. Planta Med 1981;42(1):62-68. View abstract.
  • Herrera-Arellano, A., Luna-Villegas, G., Cuevas-Uriostegui, M. L., Alvarez, L., Vargas-Pineda, G., Zamilpa-Alvarez, A., and Tortoriello, J. Polysomnographic Evaluation of the Hypnotic Effect of Valeriana edulis Standardized Extract in Patients Suffering from Insomnia. Planta Med 2001;67(8):695-699. View abstract.
  • Houghton, P. J. The biological activity of Valerian and related plants. J Ethnopharmacol. 1988;22(2):121-142. View abstract.
  • Hubner, R., van, Haselen R., and Klein, P. Effectiveness of the homeopathic preparation Neurexan compared with that of commonly used valerian-based preparations for the treatment of nervousness/restlessness - an observational study. ScientificWorldJournal. 2009;9:733-745. View abstract.
  • Jansen W. Doppelblindstudie mit Baldrisedon. Therapiewoche 1977;27:2779-2786.
  • Kamm-Kohl AV, Jansen W, and Brockmann P. Moderne baldriantherapie gegen nervöse Störungen im Senium. Medwelt 1984;35:1450-1454.
  • Khom, S., Baburin, I., Timin, E., Hohaus, A., Trauner, G., Kopp, B., and Hering, S. Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology 2007;53(1):178-187. View abstract.
  • Kim-Kohl AV, Jansen W Brickman P. Modern Baldriantherapie gegen nervöse Störungen im Senium. Die Medizinische Welt 1984;35:1450-1454.
  • Komori, T., Matsumoto, T., Motomura, E., and Shiroyama, T. The sleep-enhancing effect of valerian inhalation and sleep-shortening effect of lemon inhalation. Chem Senses 2006;31(8):731-737. View abstract.
  • Leathwood, P. D. and Chauffard, F. Quantifying the effects of mild sedatives. J Psychiatr.Res 1982;17(2):115-122. View abstract.
  • Lin, S., Zhang, Z. X., Chen, T., Ye, J., Dai, W. X., Shan, L., Su, J., Shen, Y. H., Li, H. L., Liu, R. H., Xu, X. K., Wang, H., and Zhang, W. D. Characterization of chlorinated valepotriates from Valeriana jatamansi. Phytochemistry 2013;85:185-193. View abstract.
  • Management of insomnia: a place for traditional herbal remedies. Prescrire.Int. 2005;14(77):104-107. View abstract.
  • Mennini T, Bernasconi P, Bombardelli E, and et al. In vitro study on the interaction of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine and barbiturate receptors in rat brain. Fitoterapia 1993;64(4):291-300.
  • Morazzoni P and Bombardelli E. Valeriana officinalis: traditional use and recent evaluation of activity. Fitoterapia 1995;66(2):99-112.
  • Muller, Z., Sarkany, A., Altorjay, A., Szilagyi, A., Tura, T., and Ozsvar, Z. [Liver failure a la Eastern Europe]. Orv.Hetil. 3-22-2009;150(12):555-557. View abstract.
  • National Toxicology Program, US Department of Health and Human Services. Chemical Information Review Document for Valerian (Valeriana officinalis L.) [CAS No. 8057-49-6] and Oils [CAS No. 8008-88-6]. 2009;
  • Navarrete, A., Avula, B., Choi, Y. W., and Khan, I. A. Chemical fingerprinting of valeriana species: simultaneous determination of valerenic acids, flavonoids, and phenylpropanoids using liquid chromatography with ultraviolet detection. J AOAC Int 2006;89(1):8-15. View abstract.
  • Nieves J and Oritz J G. Effects of valeriana officinalis extract on GABAergic transmission. Journal of Neurochemistry 1997;69(Suppl 1):S128.
  • Notter, D., Brattstrom, A., and Ullrich, N. Therapie von Schlafsto¨rungen. DAZ 2004;144(14):147-148.
  • Orth-Wagner S, Ressin W, and Friederich I. Phytosedative for sleeping disorders containing extracts from valerian root, hop grains and balm leaves. Zeitschrift fur Phytotherapie 1995;16:147, 155-152, 156.
  • Ortiz, J. G., Nieves-Natal, J., and Chavez, P. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. Neurochem.Res 1999;24(11):1373-1378. View abstract.
  • Oshima, Y., Matsuoka, S., and Ohizumi, Y. Antidepressant principles of Valeriana fauriei roots. Chem.Pharm.Bull.(Tokyo) 1995;43(1):169-170. View abstract.
  • Panijel M. [Treatment of moderately severe anxiety states]. Therapiewoche 1985;35(41):4659-4668.
  • Riemann, D. and Hajak, G. [Insomnias. II. Pharmacological and psychotherapeutic treatment options]. Nervenarzt 2009;80(11):1327-1340. View abstract.
  • Rodenbeck A, Simen S, Cohrs S, and et al. Alterations of the sleep stage structure as a feature of GABAergic effects of a valerian-hop preparation in patients with psychophysiological insomnia. Somnologie 1998;2:26-31.
  • Sakamoto, T., Mitani, Y., and Nakajima, K. Psychotropic effects of Japanese valerian root extract. Chem Pharm Bull (Tokyo) 1992;40(3):758-761. View abstract.
  • Salter, S. and Brownie, S. Treating primary insomnia - the efficacy of valerian and hops. Aust.Fam.Physician 2010;39(6):433-437. View abstract.
  • Santos, M. S., Ferreira, F., Cunha, A. P., Carvalho, A. P., and Macedo, T. An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Med. 1994;60(3):278-279. View abstract.
  • Santos, M. S., Ferreira, F., Cunha, A. P., Carvalho, A. P., Ribeiro, C. F., and Macedo, T. Synaptosomal GABA release as influenced by valerian root extract-- involvement of the GABA carrier. Arch.Int.Pharmacodyn.Ther. 1994;327(2):220-231. View abstract.
  • Sarris, J. and Byrne, G. J. A systematic review of insomnia and complementary medicine. Sleep Med Rev. 2011;15(2):99-106. View abstract.
  • Schellenberg R, Schwartz A, Schellenberg V, and et al. Quantitative EEG-monitoring and psychometric evaluation of the therapeutic efficacy of Biral N in psychosomatic diseases. Naturamed 1994;4:9.
  • Schmidt-Voigt J. Die Behandlung nervöser Schlafstörungen und innerer Unruhe mit einem rein pflanzlichen Sedativum. Therapiewoche 1986;36:663-667.
  • Seifert T. Therapeutic effects of valerian in nervous disorders. Therapeutikon 1988;2:94-98.
  • Sichardt, K., Vissiennon, Z., Koetter, U., Brattstrom, A., and Nieber, K. Modulation of postsynaptic potentials in rat cortical neurons by valerian extracts macerated with different alcohols: involvement of adenosine A(1)- and GABA(A)-receptors. Phytother Res 2007;21(10):932-937. View abstract.
  • Sleep complaints: Whenever possible, avoid the use of sleeping pills. Prescrire.Int. 2008;17(97):206-212. View abstract.
  • Sousa MPd, Pacheco P, and Roldao V. Double-blind comparative study of the efficacy and safety of Valdispert vs. clobazepam. KaliChemi Med Research Info (Report) 1992;
  • Staiger, C. and Wegener, T. Pflanzliche Dreierkombination bei Schlafsto¨rungen und Unruhezusta¨nden: eine Anwendungsbeobachtung. Z Phytother 2006;27(1):12-15.
  • Stevinson C and Ernst E. Valerian for insomnia: systematic review of randomized clinical trials. Sleep Med 2000;1:91-99.
  • Strosser, W. and Gladbach, B. Pflanzliche Sedativa: alternative in der Therapie leichter Schlafstorungen. Dtsch Apoth Ztg 1999;139:50-52.
  • Taibi, D. M., Landis, C. A., Petry, H., and Vitiello, M. V. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev 2007;11(3):209-230. View abstract.
  • Vassiliadis, T., Anagnostis, P., Patsiaoura, K., Giouleme, O., Katsinelos, P., Mpoumponaris, A., and Eugenidis, N. Valeriana hepatotoxicity. Sleep Med 2009;10(8):935. View abstract.
  • Volk, S., Friede, M., Hasenfuss, I., and Wustenberg, P. Phytosedativum gegen nervose Unruhezustande und Einschlafstorungen: Wirksamkeit und Vetraglichkeit eines pflanzlichen Kombinations-praparates aus Baldrianwurzeln, Hopfenzapfen und Melissenblattern. Z Phytother 1999;20(6):337-344.
  • Vorbach EU, Darmstadt R, Gortelmeyer, Frankfurt, and Bruning J. Therapie von Insomnien. Psychopharmakotherapie 1996;3:109-115.
  • Waldschutz, R. and Klein, P. The homeopathic preparation Neurexan vs. valerian for the treatment of insomnia: an observational study. ScientificWorldJournal. 2008;8:411-420. View abstract.
  • Wells SR. International intravenous administration of a crude valerian root extract. NACCT 1995;33:542.
  • Xu, J., Guo, Y., Xie, C., Jin, D. Q., Gao, J., and Gui, L. Isolation and neuroprotective activities of acylated iridoids from Valeriana jatamansi. Chem Biodivers. 2012;9(7):1382-1388. View abstract.
  • Xu, J., Li, Y., Guo, Y., Guo, P., Yamakuni, T., and Ohizumi, Y. Isolation, structural elucidation, and neuroprotective effects of iridoids from Valeriana jatamansi. Biosci.Biotechnol.Biochem. 2012;76(7):1401-1403. View abstract.
  • Yao, M., Ritchie, H. E., and Brown-Woodman, P. D. A developmental toxicity-screening test of valerian. J Ethnopharmacol 9-5-2007;113(2):204-209. View abstract.
  • Albrecht M, Berger W, Laux P, Schmidt U, et al. Psychopharmaka und Verkehrssicherheit. Der Einfluß von Euvegal&reg; - Dragees forte auf die Fahrtüchtigkeit und Kombinationswirkungen mit Alkohol Z Allg Med 1995;71:1215-25.
  • Anderson GD, Elmer GW, Kantor ED, et al. Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects. Phytother Res 2005;19:801-3. View abstract.
  • Andreatini R, Sartori VA, Seabra ML, Leite JR. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res 2002;16:650-4.. View abstract.
  • Aydinoglu U, Özcan H, Yücel A, Yücel N, Mutlu M. Valerian induced hypomania: a case report. Bull Clin Psychopharma 2012;22(Suppl. 1):S63.
  • Balderer G, Borbély AA. Effect of valerian on human sleep. Psychopharmacology (Berl) 1985;87:406-9. View abstract.
  • Barton DL, Atherton PJ, Bauer BA, et al. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5). J Support Oncol 2011;9:24-31. View abstract.
  • Bent S, Padula A, Moore D, et al. Valerian for sleep: a systematic review and meta-analysis. Am J Med 2006;119:1005-12. View abstract.
  • Bent S, Patterson M, Garvin D. Valerian for sleep: a systematic review and meta-analysis. Alternative Therapies 2001;7:S4.
  • Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000;7:273-82. View abstract.
  • Cant A, Shay J, Horrobin DF. The effect of maternal supplementation with linoleic and gamma- linolenic acids on the fat composition and content of human milk: a placebo-controlled trial. J Nutr Sci Vitaminol (Tokyo) 1991;37:573-9. View abstract.
  • Carrasco MC, Vallejo JR, Pardo-de-Santayana M, et al. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytother Res. 2009 Dec;23:1795-6. View abstract.
  • Cerny A, Shmid K. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double blind, placebo-controlled, multicentre study). Fitoterapia 1999;70:221-8.
  • Chen D, Klesmer J, Giovanniello A, et al. Mental status changes in an alcohol abuser taking valerian and gingko biloba. Am J Addict. 2002 Winter;11:75-7. View abstract.
  • Circosta C, De Pasquale R, Samperi S, et al. Biological and analytical characterization of two extracts from Valeriana officinalis. J Ethnopharmacol. 2007 Jun 13;112:361-7. View abstract.
  • Coxeter PD, Schluter PJ, Eastwood HL, et al. Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-1 trials. Complement Ther Med. 2003 Dec;11:215-22. View abstract.
  • Cropley M, Cave Z, Ellis J, Middleton RW. Effect of kava and valerian on human physiological and psychological responses to mental stress assessed under laboratory conditions. Phytother Res 2002;16:23-7.. View abstract.
  • Cuellar NG, Ratcliffe SJ. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome? Altern Ther Health Med 2009;15:22-8. View abstract.
  • Delsignore R, Orlando S, Costi D, et al. Placebo controlled clinical trial with valerian. Settimana Medica 1980;68:437-7.
  • Diaper A, Hindmarch I. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults. Phytother Res. 2004 Oct;18:831-6. View abstract.
  • Dimpfel W, Suter A. Sleep improving effects of a single dose administration of a valerian/hops fluid extract - a double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms. Eur J Med Res 2008;13:200-4. View abstract.
  • Donath F, Quispe S, Diefenbach K, et al. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 2000;33:47-53. View abstract.
  • Donovan JL, DeVane CL, Chavin KD, et al. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab Dispos 2004;32:1333-6. View abstract.
  • Dorn M. [Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomized, double-blind, clinical, comparative study]. Forsch Komplementarmed Klass Naturheilkd 2000;7:79-84. View abstract.
  • Dressing H. Valerian combination therapy vs. benzodiazepine: same efficacy in the treatment of sleeping disorders? Therapiewoche 1992;42(12):726-736.
  • Eadie MJ. Could valerian have been the first anticonvulsant? Epilepsia 2004;45:1338-43. View abstract.
  • Fernandez S, Wasowski C, Paladini AC, Marder M. Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis. Pharmacol Biochem Behav 2004;77:399-404. View abstract.
  • Fernández-San-Martín MI, Masa-Font R, Palacios-Soler L, et al. Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 2010 Jun;11:505-11. View abstract.
  • Francis AJ, Dempster RJ. Effect of valerian, Valeriana edulis, on sleep difficulties in children with intellectual deficits: randomised trial. Phytomedicine 2002;9:273-9.. View abstract.
  • Garges HP, Varia I, Doraiswamy PM. Cardiac complications and delirium associated with Valerian root withdrawal. [Letter to the Editor]. JAMA 1998;280:1566-7. View abstract.
  • Glass JR, Sproule BA, Herrmann N, et al. Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects. J Clin Psychopharmacol 2003;23:260-8. View abstract.
  • Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005;77:415-26. View abstract.
  • Gutierrez S, Ang-Lee MK, Walker DJ, Zacny JP. Assessing subjective and psychomotor effects of the herbal medication valerian in healthy volunteers. Pharmacol Biochem Behav 2004;78:57-64. View abstract.
  • Hadley S, Petry JJ. Valerian. Am Fam Physician 2003;67:1755-8.. View abstract.
  • Hellum BH, Hu Z, Nilsen OG. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin Pharmacol Toxicol. 2007 Jan;100:23-30. View abstract.
  • Hellum BH, Nilsen OG. The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol. Basic Clin Pharmacol Toxicol. 2007 Nov;101:350-8. View abstract.
  • Houghton PJ. The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol 1999;51:505-12. View abstract.
  • Jacobs BP, Bent S, Tice JA, et al. An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine (Baltimore) 2005;84:197-207. View abstract.
  • Kamm-Kohl AV, Jansen W, Brickman P. Modern Baldriantherapie gegen nervöse Störungen im Senium. Die Medizinische Welt 1984;35:1450-1454.
  • Kennedy DO, Little W, Haskell CF, et al. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res. 2006 Feb;20:96-102. View abstract.
  • Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm 1999;56:125-38. View abstract.
  • Koetter U, Schrader E, Käufeler R, et al. A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Phytother Res 2007;21:847-51. View abstract.
  • Kohnen R, Oswald WD. The effects of valerian, propranolol, and their combination on activation, performance, and mood of healthy volunteers under social stress conditions. Pharmacopsychiatry 1988;21:447-8. View abstract.
  • Kuhlmann J, Berger W, Podzuweit H, Schmidt U. The influence of valerian treatment on "reaction time, alertness and concentration" in volunteers. Pharmacopsychiatry 1999;32:235-41. View abstract.
  • Lacher SK, Mayer R, Sichardt K, et al. Interaction of valerian extracts of different polarity with adenosine receptors: identification of isovaltrate as an inverse agonist at A1 receptors. Biochem Pharmacol 2007;73(2):248-58. View abstract.
  • Leathwood PD, Chauffard F, Heck E, Munoz-Box R. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 1982;17:65-71. View abstract.
  • Leathwood PD, Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Med 1985;2:144-8. View abstract.
  • Lefebvre T, Foster BC, Drouin CE, et al. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J Pharm Pharmaceut Sci 2004;7:265-73. View abstract.
  • Li MK, Blacklock NJ, Garside J. Effects of magnesium on calcium oxalate crystallization. J Urol 1985;133:23. View abstract.
  • Lindahl O, Lindwall L. Double blind study of a valerian preparation. Pharmacol Biochem Behav. 1989 Apr;32:1065-6. View abstract.
  • MacGregor FB, Abernethy VE, Dahabra S, et al. Hepatotoxicity of herbal remedies. BMJ 1989;299:1156-7. View abstract.
  • Maroo N, Hazra A, Das T. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Indian J Pharmacol 2013;45(1):34-9. View abstract.
  • Mirabi P, Dolatian M, Mojab F, et al. Effects of valerian on the severity and systemic manifestations of dysmenorrhea. Int J Gynaecol Obstet. 2011 Dec;115:285-8. View abstract.
  • Mirabi P, Mojab F. The effects of valerian root on hot flashes in menopausal women. Iran J Pharm Res 2013;12(1):217-22. View abstract.
  • Miyasaka LS, Atallah AN, Soares BG. Valerian for anxiety disorders. Cochrane Database Syst Rev 2006;(4):CD004515. View abstract.
  • Morin CM, Koetter U, Bastien C, et al. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep 2005;28:1465-71. View abstract.
  • Müller D, Pfeil T, von den Driesch V. Treating depression comorbid with anxiety--results of an open, practice-oriented study with St John's wort WS 5572 and valerian extract in high doses. Phytomedicine. 2003;10 Suppl 4:25-30. View abstract.
  • Muller SF, Klement S. A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine 2006;13:383-7. View abstract.
  • Müller-Limmroth W, Ehrenstein W. [Experimental studies of the effects of Seda-Kneipp on the sleep of sleep disturbed subjects; implications for the treatment of different sleep disturbances (author's transl)]. Med Klin. 1977 Jun 24;72:1119-25. View abstract.
  • National Toxicology Program, US Department of Health and Human Services. Chemical Information Review Document for Valerian (Valeriana officinalis L.) [CAS No. 8057-49-6] and Oils [CAS No. 8008-88-6]. Supporting Nomination for Toxicological Evaluation by the National Toxicology Program. November 2009. http://ntp.niehs.nih.gov/NTP/Noms/Support_Docs/Valerian_nov2009.pdf.
  • O'Dell BL. Mineral interactions relevant to nutrient requirements. J Nutr 1989;119:1832-8. View abstract.
  • Oxman AD, Flottorp S, Håvelsrud K, et al. A televised, web-based randomised trial of an herbal remedy (valerian) for insomnia. PLoS One 2007 Oct 17;2:e1040. View abstract.
  • Panijel M. [Treatment of moderately severe anxiety states]. Therapiewoche 1985;35(41):4659-4668.
  • Plushner SL. Valerian: Valerian officinalis. Am J Health Syst Pharm 2000;57:328,333,335. View abstract.
  • Poyares DR, Guilleminault C, Ohayon MM, Tufik S. Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Prog Neuropsychopharmacol Biol Psychiatry 2002;26:539-45. View abstract.
  • Prudden JF, Balassa LL. The biological activity of bovine cartilage preparations. Clinical demonstration of their potent anti-inflammatory capacity with supplementary notes on certain relevant fundamental supportive studies. Semin Arthritis Rheum 1974;3:287-321.
  • Schmitz M, Jäckel M. [Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep interruption disorders) treated with a hops-valarian preparation and a benzodiazepine drug]. Wien Med Wochenschr. 1998;148:291-8. View abstract.
  • Schulz H, Stolz C, Müller J. The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry. 1994 Jul;27:147-51. View abstract.
  • Stevinson C, Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Med 2000;1:91-9. View abstract.
  • Sun J. Morning/evening menopausal formula relieves menopausal symptoms: a pilot study. J Altern Complement Med 2003;9:403-9. View abstract.
  • Taavoni S, Ekbatani N, Kashaniyan M, et al. Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial. Menopause. 2011 Sep;18:951-5. View abstract.
  • Taavoni S, Nazem Ekbatani N, Haghani H. Valerian/lemon balm use for sleep disorders during menopause. Complement Ther Clin Pract 2013;19(4):193-6. View abstract.
  • Taibi DM, Bourguignon C, Gill Taylor A. A feasibility study of valerian extract for sleep disturbance in person with arthritis. Biol Res Nurs 2009;10:409-17. View abstract.
  • Taibi DM, Vitiello MV, Barsness S, et al. A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia. Sleep Med. 2009 Mar;10:319-28. View abstract.
  • Takeshita S, Takeshita J. A case of hyponatremia due to self-treatment of anxiety with a beverage containing valerian root. Prim Care Companion CNS Disord 2013;15(1). pii: PCC.12l01482. View abstract.
  • Verhoeven E, Capron A, Hantson P. Pink urine. Clin Toxicol (Phila) 2014;52(9):980-1. View abstract.
  • Vissiennon Z, Sichardt K, Koetter U, et al. Valerian extract Ze 911 inhibits postsynaptic potentials by activation of adenosine A1 receptors in rat cortical neurons. Planta Med 2006;72(7):579-83. View abstract.
  • Vorbach EU, Darmstadt R, Gortelmeyer, Frankfurt, Bruning J. Therapie von Insomnien. Psychopharmakotherapie 1996;3:109-115.
  • Wheatley D. Stress-induced insomnia treated with kava and valerian: singly and in combination. Hum Psychopharmacol 2001;16:353-6. View abstract.
  • Willey LB, Mady SP, Cobaugh DJ, Wax PM. Valerian overdose: a case report. Vet Hum Toxicol 1995;37:364-5. View abstract.
  • Yuan CS, Mehendale S, Xiao Y, et al. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 2004;98:353-8. View abstract.
  • Ziegler G, Ploch M, Miettinen-Baumann A, et al. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study. Eur J Med Res. 2002 Nov 25;7:480-6. View abstract.

More Resources for VALERIAN

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version. © Therapeutic Research Faculty 2009.